Streetbeat News

Revenues

THC

Tenet Healthcare has revised its FY24 net operating revenues outlook to a range of $20.60B - $20.80B, slightly below the previous estimate. However, it has raised its adjusted EPS guidance to $11.12 - $11.73, surpassing the previous estimate.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 12:07 pm

OESX

Orion Energy Systems, Inc. (NASDAQ:OESX) reported preliminary Q2 2025 revenue of $19.4M, a decrease from $20.6M in Q2 2024. The company revised its FY25 revenue growth outlook to 10% over FY24, down from 10-15%, due to project delays in LED lighting. EV charging revenue rose 40%, while LED lighting revenue declined 20%. Maintenance services revenue increased by 5%. Orion expects stronger revenue in Q4 2025.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 12:04 pm

WGS

GeneDx has raised its 2024 revenue guidance to $284M-$290M, up from $255M-$265M, surpassing the consensus of $263.37M. The company also expects to improve its adjusted gross margin to at least 62% and reduce net cash usage to $60M-$65M.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 12:04 pm

IPGP

IPG Photonics has provided guidance for Q4 2024, expecting revenue between $210M and $240M, and adjusted EPS between $0.05 and $0.35, compared to estimates of $228.45M and $0.20 respectively. The guidance excludes Russian operations sold in Q3.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 12:03 pm

SYY

Sysco has reiterated its guidance for the fiscal year 2025, indicating confidence in its future performance and strategic plans.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 12:02 pm

SYY

Sysco's Q1 2025 earnings per share missed estimates, but sales exceeded expectations. EPS was $1.09, below the $1.13 estimate, while sales were $20.5 billion, surpassing the $20.463 billion estimate.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 12:01 pm

ON

Analysts have mixed views on ON Semiconductor (NASDAQ:ON) with recent ratings showing a slight negative shift in sentiment. The average 12-month price target is $82.75, down by 2.65%. The company faces challenges with a -17.15% revenue decline but shows strong profitability and financial health.

Portfolio Pulse from Benzinga Insights

October 29, 2024 | 12:01 pm

ECL

Ecolab reported Q3 2024 earnings per share of $1.83, slightly beating the estimate of $1.82. However, sales were $4.00 billion, missing the $4.04 billion estimate. Sales increased by 1.02% compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 12:01 pm

ALKT

Analysts have shown a positive shift in sentiment towards Alkami Technology (NASDAQ:ALKT), with several raising their price targets and ratings. The average 12-month price target has increased by 17.8% to $37.86. Alkami Technology, a cloud-based digital banking solutions provider, has shown strong revenue growth but faces challenges with profitability and asset utilization.

Portfolio Pulse from Benzinga Insights

October 29, 2024 | 12:01 pm

PFE

Pfizer reported strong Q3 earnings with a significant increase in revenue and profit, driven by high demand for its COVID-19 products, Paxlovid and Comirnaty. The company raised its 2024 revenue and EPS guidance, expecting $10 billion from COVID products.

Portfolio Pulse from Vandana Singh

October 29, 2024 | 12:01 pm